Anknuten till Forskning
Senior consultant in oncology and internal medicine Karolinska Comprehensive Cancer Center
Clinician Scientist and principal investigator
Principal Investigator (PI) for three clinical, academic-initiated studies; the Cogni-Thyr study (NCT05088187) and the upcoming MIMIR-mTNBC trial (EU CT 2022-500808-21-00, study start November 2022), as well as the terminated PREDIX II HER2 trial (NCT03894007).
Co-PI in the HER2-PET (EU CT 2022-000486-41) and Neo-ACT (NCT05184582) investigator-initiated trials. In addition, I coordinate a number of side-studies to already running and completed clinical trials, such as a cognition substudy to the OptiTrain clinical trial (NCT02522260) and a PET-scan substudy in the PREDIX HER2 trial (NCT02568839). I am local PI for other multicenter clinical trials, both academic as well as industry-initiated studies.
Broadly, my ongoing research activities can be divided into two topics;
a) Molecular nuclear imaging to improve precision medicine by refining therapy selection.
b) Improved understanding of cancer treatment-related toxicities and thereby enhancing healthy cancer survivorship.
Over 170 hours teaching to undergraduate and doctoral students
Courses - KI's Grundläggande Högskolpedagogik (2019); Teach the Teacher (2012)